HomeCompareMYSPX vs JNJ

MYSPX vs JNJ: Dividend Comparison 2026

MYSPX yields 0.87% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MYSPX wins by $889.00 in total portfolio value
10 years
MYSPX
MYSPX
● Live price
0.87%
Share price
$67.32
Annual div
$0.59
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.9K
Annual income
$92.34
Full MYSPX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — MYSPX vs JNJ

📍 MYSPX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMYSPXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MYSPX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MYSPX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MYSPX
Annual income on $10K today (after 15% tax)
$74.16/yr
After 10yr DRIP, annual income (after tax)
$78.49/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $625.12/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MYSPX + JNJ for your $10,000?

MYSPX: 50%JNJ: 50%
100% JNJ50/50100% MYSPX
Portfolio after 10yr
$20.5K
Annual income
$460.06/yr
Blended yield
2.25%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MYSPX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MYSPX buys
0
JNJ buys
0
No recent congressional trades found for MYSPX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMYSPXJNJ
Forward yield0.87%3.36%
Annual dividend / share$0.59$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$20.9K$20.0K
Annual income after 10y$92.34$827.78
Total dividends collected$900.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MYSPX vs JNJ ($10,000, DRIP)

YearMYSPX PortfolioMYSPX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,787$87.25$10,676$355.77+$111.00MYSPX
2$11,630$87.96$11,407$389.39+$223.00MYSPX
3$12,533$88.63$12,198$426.53+$335.00MYSPX
4$13,500$89.27$13,056$467.62+$444.00MYSPX
5$14,534$89.86$13,987$513.12+$547.00MYSPX
6$15,642$90.42$14,998$563.56+$644.00MYSPX
7$16,828$90.94$16,098$619.52+$730.00MYSPX
8$18,098$91.44$17,295$681.69+$803.00MYSPX
9$19,456$91.90$18,599$750.82+$857.00MYSPX
10$20,911$92.34$20,022$827.78+$889.00MYSPX

MYSPX vs JNJ: Complete Analysis 2026

MYSPXStock

The investment seeks investment results that correspond to the total return performance (reflecting reinvestment of dividends) of common stocks in the aggregate, as represented by the S&P 500® Index. The fund normally invests at least 80% of its assets (net assets plus any borrowings for investment purposes) in stocks as represented in the Standard & Poor's 500® Index in the same proportion, to the extent feasible. It may invest up to 20% of its total assets in options and futures contracts to maintain cash reserves, while being fully invested, to facilitate trading or to reduce transaction costs.

Full MYSPX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this MYSPX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MYSPX vs SCHDMYSPX vs JEPIMYSPX vs OMYSPX vs KOMYSPX vs MAINMYSPX vs ABBVMYSPX vs MRKMYSPX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.